Zanubrutinib in Chronic Lymphocytic Leukemia
N Engl J Med
.
2023 May 4;388(18):1719-1720.
doi: 10.1056/NEJMc2302350.
Authors
John C Byrd
1
,
Wayne Rothbaum
2
Affiliations
1
University of Cincinnati, Cincinnati, OH byrd2jc@ucmail.uc.edu.
2
Kartos Therapeutics, Redwood City, CA.
PMID:
37133595
DOI:
10.1056/NEJMc2302350
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Leukemia, Lymphocytic, Chronic, B-Cell* / drug therapy
Lymphoma, B-Cell*
Piperidines / therapeutic use
Substances
zanubrutinib
ibrutinib
Piperidines